AzurRx BioPharma, Inc. logo

AZRX

AzurRx BioPharma, Inc. · NASDAQ

Website

AzurRx BioPharma, Inc. (AZRX) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for AZRX in the last 30 days. The most recent was published Sep 28, 2021.

AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. Its therapeutic products administer patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency. It is also developing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, including FW-420, for grade 1 Immune Checkpoint Inhibitor-associated colitis and diarrhea in oncology patients; and FW-1022, for COVID-19 gastrointestinal infections. AzurRx BioPharma, Inc. has a license agreement with First Wave Bio, Inc. The company was incorporated in 2014 and is based in Boca Raton, Florida.

Latest news

25 items

AZRX FAQ

8 questions
  • What does AzurRx BioPharma, Inc. do?
    AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. Its therapeutic products administer patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency. It is also developing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, including FW-420, for grade 1 Immune Checkpoint Inhibitor-associated colitis and diarrhea in oncology...
  • What is the latest news on AZRX?
    Quantisnow has not tracked any new filings, ratings or press releases for AZRX in the last 30 days. The most recent wire item was published on September 28, 2021.
  • Where does AZRX stock trade?
    AzurRx BioPharma, Inc. (AZRX) is listed on NASDAQ.
  • What sector and industry is AZRX in?
    AzurRx BioPharma, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
  • When did AzurRx BioPharma, Inc. go public?
    AzurRx BioPharma, Inc. (AZRX) completed its IPO in 2016.
  • What are analysts saying about AZRX?
    AzurRx BioPharma, Inc. has had 1 recent analyst action on file. The most recent action was from HC Wainwright & Co.: Buy with a $2.00 price target on 2021-08-02. Recent price targets cluster around $2.00.
  • What companies are similar to AZRX?
    Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare AZRX side-by-side with any of them on Quantisnow.
  • How can I track AZRX on Quantisnow?
    Quantisnow aggregates AzurRx BioPharma, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AZRX to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change